News & Blog
David P. King joins Truvian’s Advisory Board
Aspen Neuroscience Announces Completion of First and Second Cohorts in ASPIRO Phase 1/2a Trial for Parkinson’s Disease
Truvian Health Appoints Dr. Tina Nova to its Board of Directors
SonoThera Presents New Data at the American Society of Hematology (ASH) Annual Meeting Demonstrating the Potential of Targeted, Ultrasound-Mediated Gene Delivery to Liver
Nobias Therapeutics Announces Strategic Focus and New Leadership
Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at UBS Global Healthcare Conference
In the News: Biotechnology’s Security Frontier: Navigating Innovation and Safeguards
Q3 2024 MEC Newsletter
Study PRO-101: Experience implementing an ALS community advisory board in early phase drug development
Endpoints News Honors Aspen Neuroscience Co-Founder Dr. Jeanne Loring in “20 Women Breaking New Ground”